Enanta Pharmaceuticals (ENTA) Receivables - Net: 2012-2025
Historic Receivables - Net for Enanta Pharmaceuticals (ENTA) over the last 13 years, with Sep 2025 value amounting to $6.9 million.
- Enanta Pharmaceuticals' Receivables - Net rose 3.55% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 3.55%. This contributed to the annual value of $6.9 million for FY2025, which is 3.55% up from last year.
- As of Q3 2025, Enanta Pharmaceuticals' Receivables - Net stood at $6.9 million, which was down 17.41% from $8.3 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Receivables - Net registered a high of $27.6 million during Q4 2021, and its lowest value of $6.6 million during Q3 2024.
- Over the past 3 years, Enanta Pharmaceuticals' median Receivables - Net value was $8.2 million (recorded in 2023), while the average stood at $9.6 million.
- In the last 5 years, Enanta Pharmaceuticals' Receivables - Net increased by 15.93% in 2021 and then tumbled by 63.81% in 2023.
- Enanta Pharmaceuticals' Receivables - Net (Quarterly) stood at $27.6 million in 2021, then fell by 18.31% to $22.6 million in 2022, then plummeted by 63.81% to $8.2 million in 2023, then declined by 5.57% to $7.7 million in 2024, then grew by 3.55% to $6.9 million in 2025.
- Its last three reported values are $6.9 million in Q3 2025, $8.3 million for Q2 2025, and $6.8 million during Q1 2025.